One Lot of Adbry Recalled
February 25, 2026
On Feb. 12, 2026, LEO Pharma initiated a voluntary US recall of Adbry® (tralokinumab ldrm) 300 mg/2mL single dose autoinjector.
Orders may be delayed due to Winter Weather. Learn more.
Express Scripts® Pharmacy Benefit Services
After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. Please visit the U.S. Food and Drug Administration (FDA) website for the most up-to-date information on drug safety and recalls.
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.